ArticleCureus2025
Evaluating the Balloon-Assisted Rapid Intermittent Sequential Coiling Technique for the Treatment of Wide-Neck Cerebral Aneurysms.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBalloon-assisted coiling (BAC) is acknowledged as an auxiliary method for the endovascular treatment of difficult wide-necked cerebral aneurysms (WNCAs). An intracranial stent may be necessary as a supportive scaffold when the anatomical conditions are unfavorable, as BAC alone may be inadequate to avoid coil protrusion into the parent artery. We aimed to evaluate the safety of the balloon-assisted rapid intermittent sequential coiling technique (BARISCT) and the effectiveness of BARISCT in reducing the risk of coil prolapse in the primary artery during the coiling of WNCA. METHODOLOGY: From March 2021 to April 2023, a quasi-experimental investigation was conducted on more than 19 patients with WNCA who visited the Neurointervention Unit at Suez Canal University Hospital and fulfilled the inclusion criteria of WNCA, specifically defined by an unfavorable dome-to-neck ratio of less than 2 or a neck length exceeding 4 mm.
resultsBARISCT has proven to be a safe and successful tool for occluding ruptured and unruptured WNCA, with a full occlusion rate of roughly 73% with minimum sequelae and no major complications.
conclusionBARISCT seems to be a method that is both safe and successful for the endovascular treatment of wide-neck intracranial aneurysms (WNCA), with no concern regarding the potential for an increase in the likelihood of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.